Discover Seventure's video
Next decade set to herald industry confidence in microbiome-based therapies, says new report
Taking on board learnings from challenges already faced...
Galecto Biotech Raises €79 Million in Series C Financing Co-Led by Ysios Capital and OrbiMed to Advance Galectin Inhibitor to Late-Stage Clinical Development
Proceeds to fund Phase 2/3 trial of inhaled TD139 in...
Microbiotica Attracts Equity Investment from Seventure’s Health for Life Capital™ Fund
The company, which was founded in 2016 to develop...
Enterome signs global licensing, co-development and co-promotion agreement with Takeda for the treatment of Crohn’s disease
Enterome, a clinical-stage biotech company developing...
LNC Therapeutics acquires exclusive license for the Christensenella patent from Cornell University
LNC aims to develop the first Christensenella-based drug...
France Digitale Day, Paris
Come & meet us !
Fintech Tour – 4 October 2018 – MARSEILLE
Come & meet us ! http://bit.ly/2Ck2iBo
Microbiome Drug Development Summit – Paris, 29-31 January